Key Statistics for 600664
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CNY) (ttm)
|Est. EPS (CNY) (12/2013)
|Est. PEG Ratio
|Market Cap (M CNY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CNY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 600664
- Net Income (M/CNY)
Harbin Pharmaceutical Group Co., Ltd. develops and manufactures a variety of medicines, preparations, Chinese traditional medicines, healthcare products, and biopharmaceuticals. The Company's main products include penicillin, calcium gluconate, etc.
More Company Profile & Key Executives for 600664
|Zhang LijunChairman/President||Wu ZhijunVice President|
|Meng XiaodongVP/Secretary||Liu BoChief Accountant|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries